GALECTIN THERAPEUTICS INC. (GALT) Operating cash flow 2016–2025
GALECTIN THERAPEUTICS INC. (GALT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.9MFY2025 · since FY2016: -$16.4M → -$23.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.9M | +42.8% |
| FY2024 | -$41.8M | -26.7% |
| FY2023 | -$33.0M | -6.1% |
| FY2022 | -$31.1M | -27.8% |
| FY2021 | -$24.3M | -18.0% |
| FY2020 | -$20.6M | -89.9% |
| FY2019 | -$10.8M | -6.6% |
| FY2018 | -$10.2M | +35.9% |
| FY2017 | -$15.9M | +3.2% |
| FY2016 | -$16.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice